Health News & Analysis

The S&P 500 is taking a solid 1.23% February gain into the holiday-shortened week, with Walmart earnings and peace talks in focus.

Level Zero Health, a female-founded medical device startup that’s aiming to break new ground by developing a device for continuous hormone monitoring, has closed an oversubscribed $6.9 million pre-seed funding round despite being only a little ov…

We all know headphones can be bad for your hearing if you listen to sounds too loudly in such close proximity to your ears. But a BBC report suggests that a new health scare could be emerging around the noise-canceling feature that’s hugely popul…

Beyond analysts’ top -and-bottom-line estimates for Evolent Health (EVH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.

Looking beyond Wall Street’s top -and-bottom-line estimate forecasts for Guardant Health (GH), delve into some of its key metrics to gain a deeper insight into the company’s potential performance for the quarter ended December 2024.

Mutual Fund Report for FSHCX

Your health span isn’t pre-determined—there are things you can do to increase it.

Elon Musk’s AI startup xAI plans to continue using 15 gas turbines to power its “Colossus” supercomputer in Memphis, Tennessee, according to an operating permit with the Shelby County Health Department for non-stop turbine use from Ju…

Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade-offs.

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $60.30, signifying a +1.88% move from its prior day’s close.

Workplaces have started offering more customized benefits over the past decade, even including niche offerings that help employees navigate major life changes like divorce. As demand has increased for fertility coverage and mental health support, for …

USNA vs. STVN: Which Stock Is the Better Value Option?

These five S&P 500 stocks look like incredible contrarian ideas for growth and income investors. They pay dependable dividends, have Buy ratings, and are down handily over the past year.

The post Buy the Biggest S&P 500 Losers: 5 High-Yield Dividend Companies Are On Sale appeared first on 24/7 Wall St..

Mutual Fund Report for VGHCX

PAHC made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 14, 2025.

Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Road congestion is a persistent thorn in the side of our car-centric society. It’s loud, stressful, dangerous, and worsens air quality. It’s been linked to all kinds of adverse health effects, including lower birth weights, memory and attention proble…

The Senate on Thursday confirmed Robert F. Kennedy Jr. as President Donald Trump’s health secretary, putting the prominent vaccine skeptic in control of $1.7 trillion in federal spending, vaccine recommendations and food safety as well as health insur…

Republicans fell in line behind Trump despite hesitancy over Kennedy’s views on vaccines.

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.

Hologic’s Surgical business has been recording strong broad-based performance by expanding access to technologies into new global markets.

Zoetis (ZTS) delivered earnings and revenue surprises of 2.19% and 0.68%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Mutual Fund Report for FSPHX

CareTrust REIT (CTRE) delivered FFO and revenue surprises of 0% and 3.42%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Cheerios and Wheaties are pumping up the protein. It’s all part of a big vibe shift I’ve noticed lately with health trends, fueled by social media.

Dr. Lawrence Tabak, the No. 2 official at the National Institutes of Health, did not give a reason for his departure.

The Senate voted Thursday to put RFK Jr. in charge of health. It’s unclear how he will impact biotech stocks.
The post It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care appeared first on Investor's Bu…

CNO Financial’s Q4 results reflect improved collected premiums in its three product lines, partly offset by a decline in net investment income. It estimates 2025 operating EPS to stay within the band of $3.70-$3.90.

With over 1,000 insurance companies in the U.S., figuring out how to get paid by each company is a complex challenge for doctors and hospitals. Each insurance may require slightly different information on medical claims, even for the same procedure. In…

Bausch (BHC) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CVS Health earnings topped estimates and the company expects 2025 to be a turnaround year.
The post CVS Health Clears Low Earnings Bar, Leads S&P 500 On Return To Growth In '25 appeared first on Investor's Business Daily.

CVS Health (CVS) delivered earnings and revenue surprises of 33.71% and 0.67%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?